Upstate Active Clinical Trials

Study Title:

S2104 - Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

What is the purpose of the study? (in Layman's terms, please describe the study)

This study is being done to answer the following question: Can we lower the chance of pNET coming back by giving chemotherapy after surgery? The purpose of this study is to compare the usual approach (observation) to using capecitabine and temozolomide (chemotherapy).

Upstate Institutional Review Board (IRB) Number:

1947027

Study/Protocol ID:

S2104

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Rahul Seth, DO

What is involved if I participate?

• How long is the study?
  5 years
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Surgery, CTs and/or MRIs, Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP)

Where will the study take place?

Upstate University Hospital - Downtown Campus

Other Information:

N/a

ClinicalTrials.Gov ID:

NCT05040360

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Amelia Bell
Phone: 315-464-5777
Email: [email protected]

Return to Previous Page || Search Again